Acute Schizophrenia

2

Review clinical trials related to Acute Schizophrenia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia

Confirm the efficacy of the brexpiprazole QW formulation versus placebo for acute symptoms of schizophrenia

Participants needed: 450
Trial details
Phase: Phase 3Age: 18-64Biological sex: AllType: InterventionalSponsor: Otsuka Pharmaceutical Co., Ltd.Updated: Mar 12, 2025Locations: 1
Eligibility criteria

Patients at least 18 years of age and below the age of 65 at the time of informe... [+6]

Patients presenting a first episode of schizophrenia based on the clinical judgm... [+17]

Status: Not yet recruiting

A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia

This is a non-Inferiority trial to evaluate efficacy and safety of hydrochloride carliprazine capsules and aripiprazole tablets in treating acute schizophrenia in Chinese adults. 376 patients will be randomizdely assigned in a 1:1 ratio to treatment group and control group. All enrolled subjects will be orally administered with hydrochloride carliprazine capsules or aripiprazole tablets for 6 consecutive weeks.

Participants needed: 376
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd.Updated: Sep 19, 2024
Eligibility criteria

Subjects between 18 and 65 years, male and female; [+5]

Other mental illnesses that meet DSM-5 criteria, excluding schizophrenia, includ... [+21]